MedTrace Logo

IMRT Lower Limb Soft Tissue Sarcoma

NCT00188175 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2014-06-03

No results posted yet for this study

Summary

Intensity-modulated radiation therapy may make wound healing problems less likely by 1)precisely shaping the region of high radiation dose to the shape of the tissue which harbours tumour cells, and 2) precisely shaping the regions of low radiation dose to the shapes of the normal tissues which are more sensitive to radiation effects.

Conditions

  • Sarcoma

Interventions

RADIATION

Intensity Modulated Radiation Therapy

Pre-op Intensity Modulated Radiation Therapy for lower limb soft tissue sarcoma.

Sponsors & Collaborators

  • Ontario Cancer Research Network

    collaborator NETWORK

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Brian O'Sullivan, MD · Princess Margaret Hospital, Canada

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00188175 on ClinicalTrials.gov